Success Metrics

Clinical Success Rate
84.2%

Based on 16 completed trials

Completion Rate
84%(16/19)
Active Trials
1(4%)
Results Posted
31%(5 trials)
Terminated
3(12%)

Phase Distribution

Ph phase_1
3
12%
Ph early_phase_1
1
4%
Ph not_applicable
19
76%
Ph phase_2
1
4%

Phase Distribution

4

Early Stage

1

Mid Stage

0

Late Stage

Phase Distribution24 total trials
Early Phase 1First-in-human
1(4.2%)
Phase 1Safety & dosage
3(12.5%)
Phase 2Efficacy & side effects
1(4.2%)
N/ANon-phased studies
19(79.2%)

Highest Phase Reached

Phase 2

Trial Status & Enrollment

Completion Rate

84.2%

16 of 19 finished

Non-Completion Rate

15.8%

3 ended early

Currently Active

1

trials recruiting

Total Trials

25

all time

Status Distribution
Active(1)
Completed(16)
Terminated(3)
Other(5)

Detailed Status

Completed16
unknown3
Terminated3
Suspended2
Recruiting1

Development Timeline

Analytics

Development Status

Total Trials
25
Active
1
Success Rate
84.2%
Most Advanced
Phase 2

Trials by Phase

Early Phase 11 (4.2%)
Phase 13 (12.5%)
Phase 21 (4.2%)
N/A19 (79.2%)

Trials by Status

unknown312%
suspended28%
recruiting14%
terminated312%
completed1664%

Recent Activity

Clinical Trials (25)

Showing 20 of 25 trialsScroll for more
NCT06567665Not Applicable

Leucine Supplementation Strategies to Enhance Muscle Anabolic Responses in Older Age

Recruiting
NCT05394155Not Applicable

Leucine Requirement in Adult Men and Women

Completed
NCT06121869Not Applicable

Dileucine and Resistance Training Adaptations

Completed
NCT03557684Early Phase 1

Leucine for Depression Study (L-DEP)

Terminated
NCT01362595Phase 1

Pilot Phase I/II Study of Amino Acid Leucine in Treatment of Patients With Transfusion-Dependent Diamond Blackfan Anemia

Completed
NCT03506126Not Applicable

Requirement for Leucine in Adults Over 60 Years

Completed
NCT03952884Not Applicable

Skeletal Muscle Protein Synthetic Response to Amino Acid and Peptides

Completed
NCT03762278Not Applicable

Can Supplemental Leucine Offset Disuse-induced Muscle Atrophy?

Completed
NCT03831399Phase 1

Leucine Supplementation in Sarcopenic Older Individuals

Completed
NCT02693106Not Applicable

Evaluation of the Ketogenic Potential of Different Diet Supplements

Completed
NCT00968344Not Applicable

Muscle Mass During Space Exploration

Completed
NCT01922167Not Applicable

Resistance Exercise Training and Amino Acid Leucine Supplementation in Frail Elderly Women

Completed
NCT01846130Not Applicable

Preserving Muscle Mass and Function in Bedridden Older Adults

Completed
NCT03668548Not Applicable

10-week Leucine Supplementation in Cerebral Palsy

Unknown
NCT03180775Not Applicable

Effects of Dietary Amino Acids on Serum and Macrophage Atherogenicity

Unknown
NCT02744443Not Applicable

Leucine Supplementation in Young Subjects Undergoing Resistance Training

Completed
NCT02371278Not Applicable

Leucine Co-ingestion and Myofibrillar Protein Synthesis in Older Adults

Completed
NCT00865514Not Applicable

Pharmacotoxicology of Trichloroethylene Metabolites

Terminated
NCT01192009Not Applicable

Leucine Supplementation and Skeletal Muscle Disuse

Completed
NCT01496768Not Applicable

Effects of Chronic Leucine Supplemetion on Glucose Homeostasis, Body Compositin, Muscle Mass and Strength of Healthy and Young Subjects

Suspended

Drug Details

Intervention Type
DIETARY SUPPLEMENT
Total Trials
25